Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Molecular Psychiatry
|
November 17, 2019
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
Bashkim Kadriu, Cristan A Farmer, Peixiong Yuan, et al.
Translational Psychiatry
|
November 19, 2025
Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study
Jenessa N Johnston, Peixiong Yuan, Bashkim Kadriu, et al.
Journal of Clinical Psychopharmacology
|
March 31, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability
Bashkim Kadriu, Shiwen Yuan, Cristan Farmer, et al.
Neuroscience and Biobehavioral Reviews
|
May 2, 2024
Exploring the impact of music on response to ketamine/esketamine: A scoping review
Mina Kheirkhah, Allison C Nugent, Alicia A Livinski, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 18, 2025
Evaluation of deuterated [<sup>18</sup>F]JHU94620 for imaging cannabinoid type 2 receptors in rodent and monkey brain
Mudasir Maqbool, Daniel Gündel, Jeih-San Liow, et al.
Translational Psychiatry
|
April 21, 2026
Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP
Paul A Parcon, Amanda Bardhoshi, Amanda Olsen-Dufour, et al.
EJNMMI Research
|
July 5, 2018
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
Erica M Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, et al.
The American Journal of Psychiatry
|
February 1, 2014
Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior
Stal Saurav Shrestha, Eric E Nelson, Jeih-San Liow, et al.
The International Journal of Neuropsychopharmacology
|
April 3, 2020
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
Lawrence T Park, Bashkim Kadriu, Todd D Gould, et al.
Frontiers in Psychiatry
|
September 18, 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial
Mina Kheirkhah, Nastasia McDonald, Julia Aepfelbacher, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Molecular Psychiatry
|
November 17, 2019
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
Bashkim Kadriu, Cristan A Farmer, Peixiong Yuan, et al.
Translational Psychiatry
|
November 19, 2025
Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study
Jenessa N Johnston, Peixiong Yuan, Bashkim Kadriu, et al.
Journal of Clinical Psychopharmacology
|
March 31, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability
Bashkim Kadriu, Shiwen Yuan, Cristan Farmer, et al.
Neuroscience and Biobehavioral Reviews
|
May 2, 2024
Exploring the impact of music on response to ketamine/esketamine: A scoping review
Mina Kheirkhah, Allison C Nugent, Alicia A Livinski, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 18, 2025
Evaluation of deuterated [<sup>18</sup>F]JHU94620 for imaging cannabinoid type 2 receptors in rodent and monkey brain
Mudasir Maqbool, Daniel Gündel, Jeih-San Liow, et al.
Translational Psychiatry
|
April 21, 2026
Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP
Paul A Parcon, Amanda Bardhoshi, Amanda Olsen-Dufour, et al.
EJNMMI Research
|
July 5, 2018
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
Erica M Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, et al.
The American Journal of Psychiatry
|
February 1, 2014
Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior
Stal Saurav Shrestha, Eric E Nelson, Jeih-San Liow, et al.
The International Journal of Neuropsychopharmacology
|
April 3, 2020
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
Lawrence T Park, Bashkim Kadriu, Todd D Gould, et al.
Frontiers in Psychiatry
|
September 18, 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial
Mina Kheirkhah, Nastasia McDonald, Julia Aepfelbacher, et al.
Page
of 8